Pre-treatment HIV-drug resistance associated with virologic outcome of first-line NNRTI-antiretroviral therapy: A cohort study in Kenya

BACKGROUND: Pre-treatment HIV-drug-resistance (PDR) to WHO-recommended 1st-line non-nucleoside reverse transcriptase inhibitors (NNRTI)-based antiretroviral treatment (ART) is increasing in low-resource communities. We evaluated the risk of PDR on treatment failure if detected at single or multiple...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:EClinicalMedicine
Autors principals: Beck, Ingrid A., Levine, Molly, McGrath, Christine J., Bii, Steve, Milne, Ross S., Kingoo, James M., So, Isaac, Andersen, Nina, Dross, Sandra, Coombs, Robert W., Kiarie, James, Chohan, Bhavna, Sakr, Samah R., Chung, Michael H., Frenkel, Lisa M.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Research paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6962698/
https://ncbi.nlm.nih.gov/pubmed/31956856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2019.100239
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars